Effect of Medicaid Coverage of Tobacco-Dependence Treatments on Smoking Cessation
IJERPH, 2009, vol. 6, issue 12, 1-13
Smoking cessation aids (nicotine replacement products and anti-depressant medication) have been proven to double quitting rates compared to placebo in several randomized controlled trials. But the high initial cost of cessation aids might create a financial barrier to cessation for low-income smokers. In the U.S., Medicaid provides health insurance coverage to low-income people, and in some states covers smoking cessation products. This paper uses nationally representative data of the U.S. to examine how the Medicaid coverage of cessation aids affect smoking behavior. The results indicate the Medicaid coverage of cessation products is positively associated with successful quitting among women aged 18–44.
Keywords: Medicaid; smoking cessation; health insurance; tobacco dependence treatment (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:6:y:2009:i:12:p:3143-3155:d:6479
Access Statistics for this article
IJERPH is currently edited by Ms. Arlene Chen
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().